Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADOAIR and Tiotropium in Japanese COPD Patients
NCT01762800Phase 4Completed
- Sponsor
- GSK
- Start
- Feb 2013
- Primary completion
- Sep 2015
- Countries
- 1
01
Overview
A Phase 4 trial of salmeterol + fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Feb 2013; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01762800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01762800.